Robert Tissue - Sumitomo Chemical Ex CFO
| SMM Stock | EUR 2.16 0.04 1.82% |
Insider
Robert Tissue is Ex CFO of Sumitomo Chemical
| Age | 60 |
| Phone | 304 530 1000 |
| Web | https://www.summitfgi.com |
Robert Tissue Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Tissue against Sumitomo Chemical stock is an integral part of due diligence when investing in Sumitomo Chemical. Robert Tissue insider activity provides valuable insight into whether Sumitomo Chemical is net buyers or sellers over its current business cycle. Note, Sumitomo Chemical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sumitomo Chemical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Tissue over a year ago Summit Financial exotic insider transaction detected | ||
Robert Tissue over a year ago Summit Financial exotic insider transaction detected | ||
Robert Tissue over a year ago Summit Financial exotic insider transaction detected | ||
Robert Tissue over a year ago Summit Financial exotic insider transaction detected |
Sumitomo Chemical Management Efficiency
The company has return on total asset (ROA) of 0.0108 % which means that it generated a profit of $0.0108 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0425 %, meaning that it generated $0.0425 on every $100 dollars invested by stockholders. Sumitomo Chemical's management efficiency ratios could be used to measure how well Sumitomo Chemical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Heinz | BASF SE | 59 | |
| Stefanie Wettberg | BASF SE | 50 | |
| Stefanie Wettberg | BASF SE | 50 | |
| HansUlrich Engel | BASF SE | 64 | |
| Markus Kamieth | BASF SE | 53 | |
| Michael Heinz | BASF SE | 59 | |
| Martin Brudermuller | BASF SE | 62 | |
| Stefan Beckmann | BASF SE | N/A | |
| Melanie MaasBrunner | BASF SE | 54 | |
| Martin Brudermuller | BASF SE | 62 | |
| Detlef Kratz | BASF SE | 61 | |
| Wolfgang Haas | BASF SE | N/A | |
| Detlef Kratz | BASF SE | 61 | |
| Saori Dubourg | BASF SE | 52 | |
| HansUlrich Engel | BASF SE | 64 | |
| Stefan Beckmann | BASF SE | N/A | |
| Markus Kamieth | BASF SE | 53 | |
| Saori Dubourg | BASF SE | 52 | |
| Melanie MaasBrunner | BASF SE | 54 | |
| Wolfgang Haas | BASF SE | N/A | |
Management Performance
| Return On Equity | 0.0425 | |||
| Return On Asset | 0.0108 |
Sumitomo Chemical Leadership Team
Elected by the shareholders, the Sumitomo Chemical's board of directors comprises two types of representatives: Sumitomo Chemical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo Chemical's management team and ensure that shareholders' interests are well served. Sumitomo Chemical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo Chemical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bradford Ritchie, Ex Bank | ||
| Robert Tissue, Ex CFO | ||
| Julie Markwood, VP Officer | ||
| Keigo Sasaki, Fin Accounting | ||
| Patricia Owens, Ex Officer | ||
| Danyl Freeman, Ex Officer | ||
| Marc Vermeire, Managing Officer | ||
| Motoyuki Sakai, Managing Officer | ||
| Charles III, Pres Chairman | ||
| Noriaki Takeshita, Sr Director | ||
| Keiichi Sakata, Managing Officer | ||
| Lorraine Brisell, Market Pres | ||
| Keiichi Iwata, Pres Director | ||
| Hiroshi Niinuma, Ex Director | ||
| Hiroshi Ueda, Ex Director | ||
| Scott Jennings, Ex COO | ||
| Teresa Ely, Ex Relations | ||
| Takashi Shigemori, Sr Officer | ||
| Patrick Frye, Ex Admin | ||
| Masaki Matsui, Sr Director |
Sumitomo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sumitomo Chemical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0425 | |||
| Return On Asset | 0.0108 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 11.49 B | |||
| Shares Outstanding | 1.64 B | |||
| Shares Owned By Insiders | 2.54 % | |||
| Shares Owned By Institutions | 54.01 % | |||
| Price To Earning | 5.97 X | |||
| Price To Book | 0.57 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sumitomo Stock
Sumitomo Chemical financial ratios help investors to determine whether Sumitomo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sumitomo with respect to the benefits of owning Sumitomo Chemical security.